We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CANF
3326
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
| $41K | ﹤0.01% |
924
| – | – |
|
|
LIAN
3327
DELISTED
LianBio American Depositary Shares
LIAN
| $40.5K | ﹤0.01% |
+125,457
| New | +$540K |
|
3328
Zura Bio
ZURA
$566M
| $39.9K | ﹤0.01% |
15,523
+556
| +4% | +$1.97K |
|
|
CWAN
3329
DELISTED
Clearwater Analytics
CWAN
| $39.8K | ﹤0.01% |
2,248
| – | – |
|
|
IMA
3330
ImageneBio Inc
IMA
$64.6M
| $39.5K | ﹤0.01% |
2,318
+75
| +3% | +$1.37K |
|
3331
Zai Lab
ZLAB
$2.62B
| $39K | ﹤0.01% |
2,432
+1,019
| +72% | +$21.5K |
|
3332
Vertex
VERX
$1.94B
| $38.7K | ﹤0.01% |
1,218
| – | – |
|
3333
iShares MSCI Norway ETF
ENOR
$96M
| $38.3K | ﹤0.01% |
1,630
| – | – |
|
3334
Urban One Class D
UONEK
$23.8M
| $38K | ﹤0.01% |
1,862
-210
| -10% | -$6.41K |
|
3335
INNOVATE Corp
VATE
$165M
| $37.8K | ﹤0.01% |
5,397
+524
| +11% | +$4.62K |
|
|
OCEA
3336
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $37K | ﹤0.01% |
9,777
-1,381
| -12% | -$2.6K |
|
|
SOL
3337
DELISTED
Emeren Group
SOL
| $35.1K | ﹤0.01% |
18,167
+5,200
| +40% | +$10.6K |
|
3338
Establishment Labs
ESTA
$2.28B
| $34.7K | ﹤0.01% |
682
| – | – |
|
3339
American Realty Investors
ARL
$248M
| $34.6K | ﹤0.01% |
1,933
+57
| +3% | +$1.17K |
|
|
VSA
3340
VisionSys AI
VSA
$10.6M
| $34.5K | ﹤0.01% |
+26
| New | +$19.3K |
|
|
AD
3341
Array Digital Infrastructure
AD
$3.05B
| $34.3K | ﹤0.01% |
939
| – | – |
|
|
XYF
3342
X Financial
XYF
$204M
| $33.8K | ﹤0.01% |
8,745
| – | – |
|
|
FOCL
3343
EDAP TMS S.A.
FOCL
$233M
| $32.9K | ﹤0.01% |
4,478
-107
| -2% | -$691 |
|
3344
Envela
ELA
$446M
| $32.9K | ﹤0.01% |
7,119
-2
| -0% | -$9 |
|
|
VAXX
3345
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
| $32K | ﹤0.01% |
44,603
+5,510
| +14% | +$3.99K |
|
3346
OppFi
OPFI
$803M
| $31.1K | ﹤0.01% |
12,448
-3,951
| -24% | -$13.4K |
|
3347
Sasol
SSL
$7.1B
| $30.7K | ﹤0.01% |
3,929
-14,217
| -78% | -$117K |
|
3348
Compañía de Cervecerías Unidas
CCU
$2.21B
| $30.5K | ﹤0.01% |
2,546
+460
| +22% | +$5.5K |
|
|
ZEPP
3349
Zepp Health
ZEPP
$69.7M
| $30.4K | ﹤0.01% |
7,452
-102
| -1% | -$526 |
|
3350
Pampa Energía
PAM
$4.41B
| $29.7K | ﹤0.01% |
689
+165
| +31% | +$7.35K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.